Okamura Noboru 岡村昇

… Alternative Names

OKAMURA Noboru 岡村昇

Less

Researcher Number	60379401
Other IDs
Affiliation (Current)	2025: 武庫川女子大学, 薬学部, 教授
Affiliation (based on the past Project Information) *help	2007 – 2017: 武庫川女子大学, 薬学部, 教授 2006: Kobe University, Graduate School of Medicine, Associate Professor, 医学系研究科, 助教授 2005: Kobe University, Graduate School of Medicine, Associate Professor, 大学院・医学系研究科, 助教授 2004: 神戸大学, 大学院・医学研究科, 助教授
Review Section/Research Field	Principal Investigator Medical pharmacy Except Principal Investigator Medical pharmacy
Keywords	Principal Investigator アポトーシス / PPARγ / 膵臓がん / 創薬ターゲット / ERCC1 / troglitazone / プロテオミクス / 腎臓がん / 臨床薬学 Except Principal Investigator Reduced folate carrier … More / Glutathione S-transferase / 遺伝子型 / Ms / MALDI-TOF / VEGF / Sorcin / 腎臓癌 / プロテオーム解析 / Genetic polymorphism / Malignant lymphoma / Acute lymphoblastic leukemia / Methotrexate / reduced folate carrier / glutathione S-transferase / 遺伝子多型 / アスパラギナーゼ / 急性膵炎 / 悪性リンパ腫 / 急性リンパ性白血病 / メトトレキサート / Renal cell carcinoma / Transcriptome analysis / Proteome analysis / EGFR / sorcin / MDR1 / トランスクリプトーム解析 / 2-nitrobenzenesulfenyl / TOF-MS / NBS試薬 / 創薬ターゲット / 診断マーカー / 2-nitrobenzensulfenyl Less

Development for novel therapy for pancreatic cancer by PPARgamma agonistsPrincipal Investigator
- Principal Investigator
  
  Okamura Noboru
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Research on the therapy for pancreatic cancer by PPARgamma agonistsPrincipal Investigator
- Principal Investigator
  
  OKAMURA Noboru
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Discovery of novel targets for the treatment of renal cell carcinoma based on tumor proteomicsPrincipal Investigator
- Principal Investigator
  
  OKAMURA Noboru
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Proteomic analysis to discover diagnostic markers in human renal call carcinoma
- Principal Investigator
  
  OKUMURA Katsuhiko
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Himeji Dokkyo University
Elucidation of adverse events of methotrexate based on genomic and proteomic analysis in childhood leukemia patients
- Principal Investigator
  
  SAKAEDA Toshiyuki
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kobe University
Discovery of targets for treatment with renal cell carcinoma by gene and protein expression profile analysis
- Principal Investigator
  
  OKUMURA Katsuhiko
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kobe University

All 2017 2016 2013 2012 2011 2010 2009 2008 2007

All Journal Article Presentation

[Journal Article] In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer2017
- Author(s)
  Fujita Megumi、Hasegawa Ai、Yamamori Motohiro、Okamura Noboru
- Journal Title
  
  Journal of Experimental & Clinical Cancer Research
  
  Volume: 36 Issue: 1 Pages: 91-91
- DOI
  10.1186/s13046-017-0557-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K08118, KAKENHI-PROJECT-15K18944
[Journal Article] TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.2013
- Author(s)
  H. Omatsu, A. Kuwahara, M. Yamamori, M. Fujita, T. Okuno, I. Miki, T. Tamura, K. Nishiguchi, N. Okamura, T. Nakamura, T. Azuma, T. Hirano, K. Ozawa, M. Hirai.
- Journal Title
  
  Int J Med Sci.
  
  Volume: 10 Issue: 12 Pages: 1755-1760
- DOI
  10.7150/ijms.6749
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] Potential tumor markers of renal cell carcinoma: α-enolase for postoperative follow-up and galectin-1 and galectin-3 for primary detection.2013
- Author(s)
  N. Kaneko, A. Gotoh, N. Okamura, E. Matsuo, S. Terao, M. Watanabe, T. Nakamura, M. Ikekita, K. Okumura, O. Nishimura.
- Journal Title
  
  Int J Urol.
  
  Volume: 20 Issue: 5 Pages: 530-535
- DOI
  10.1111/j.1442-2042.2012.03206.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] L-type voltage-dependent calcium channel is involved in the snake venom group IA secretory phospholipase A2-induced neuronal apoptosis.2013
- Author(s)
  T. Yagami, Y. Yamamoto, H. Kohma, T. Nakamura, N. Takasu, N. Okamura.
- Journal Title
  
  Neurotoxicology
  
  Volume: 35 Pages: 146-153
- DOI
  10.1016/j.neuro.2012.12.009
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.2012
- Author(s)
  Fujita M, Tohji C, Honda Y, Yamamoto Y, Nakamura T, Yagami T, Yamamori M, Okamura N.
- Journal Title
  
  Int J Med Sci
  
  Volume: 9 Issue: 7 Pages: 555-566
- DOI
  10.7150/ijms.4455
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590225
[Journal Article] Involvement of the mevalonate pathway in anti-proliferative effect of zoledronate on renal cell carcinoma2012
- Author(s)
  Fujita M, Tohi M, Sawada K, Yamamoto Y, Nakamura T, Yagami T, Yamamori M, Okamura N
- Journal Title
  
  ACHN. Oncol Rep
  
  Volume: 27 Pages: 1371-1376
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011
- Author(s)
  Fujita M, Yagami T, Fujio M, Tohji C, Takase K, Yamamoto Y, Sawada K, Yamamori M, Okamura N
- Journal Title
  
  Cancer Lett
  
  Volume: 312 Pages: 219-227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] 15-Deoxy-Δ12, 14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways2011
- Author(s)
  Yamamoto Y, Fuita M, Koma H, Yamamori M, Okamura N, Yagami T
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 410 Pages: 563-567
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Proteomic identification of protein targets for 15-deoxy-Δ12, 14-prostaglandin J2 in neuronal plasma membrane2011
- Author(s)
  Yamamoto Y, Takase K, Kishino J, Fujita M, Okamura N, Sakaeda T, Fujimoto M, Yagami T
- Journal Title
  
  PLoS One
  
  Volume: 6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer2011
- Author(s)
  Seki K, Senzaki K, Tsuduki Y, Ioroi T, Fujii M, Yamauchi, H, Shiraishi Y, Nakata I, Nishiguchi K, Matsubayashi T, Takakubo Y, Okamura N, Yamamori M, Tamura T, Sakaeda T
- Journal Title
  
  Int J Med Sci
  
  Volume: 8 Pages: 210-215
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cell2011
- Author(s)
  Fujita M, et al
- Journal Title
  
  Oncol.Rep.
  
  Volume: 27 Pages: 1371-1376
- DOI
  10.3892/or.2012.1683
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186, KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] VEGF 936C> T is predictive of threshold retinopathy of prematurity in Japanese infants with a 30-week gestational age or less2011
- Author(s)
  Yagi M, Yamamori M, Morioka I, Yokoyama N, Honda S, Negi A, Nakamura T, Okamura N, Okumura K, Sakaeda T, Matsuo M
- Journal Title
  
  Res Rep Neonatol
  
  Volume: 1 Pages: 5-11
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Effect of CPS1 4217C> A genotype on valproic acid-induced hyperammonemia2010
- Author(s)
  Yagi M, Nakamura T, Okizuka Y, Oyazato Y, Kawasaki Y, Tsuneishi S, Sakaeda T, Matsuo M, Okumura K, Okamura N
- Journal Title
  
  Pediatr Int
  
  Volume: 52 Pages: 744-748
- NAID
  10028184232
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma2010
- Author(s)
  Horinouchi M, Yagi M, Imanishi H, Mori T, Yanai T, Hayakawa A, Takeshima Y, Hijioka M, Okamura N, Sakaeda T, Matsuo M, Okumura K, Nakamura T
- Journal Title
  
  Pediatr Hematol Oncol
  
  Volume: 27 Pages: 344-354
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma2010
- Author(s)
  Kuwahara A, Yamamori M, Fujita M, Okuno T, Tamura T, Kadoyama K, Okamura N, Nakamura T, Sakaeda T
- Journal Title
  
  J Exp Clin Cancer Res
  
  Volume: 29 Pages: 100-100
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits2009
- Author(s)
  Kohno E, Murase S, Matsuyama K, Okamura N
- Journal Title
  
  Int J Med Sci
  
  Volume: 6 Pages: 218-23
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.2008
- Author(s)
  N. Okamura, 他
- Journal Title
  
  Proteomics 8
  
  Pages: 3194-3203
- NAID
  130006996715
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590167
[Journal Article] Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.2008
- Author(s)
  Okamura N, M asuda T, G otoh A, S hirakawa T, Terao S, Kaneko N, Suganuma K, Watanabe M, Matsubara T, Seto R, Matsumoto J, Kawakami M, Yamamori M, Nakamura T, Yagami T, Sakaeda T, Fujisawa M, Nishimura O, Okumura K.
- Journal Title
  
  Proteomics. 8(15)
  
  Pages: 3194-3203
- NAID
  130006996715
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590167
[Journal Article] T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese.2008
- Author(s)
  Yamamori M, Taniguchi M, Maeda S, Nakamura T, OKamura N. Kuwahara A, Iwaki K, Tamura T, Aoyama N, M arkova S, Kasuga M, Okumura K, Sakaeda T.
- Journal Title
  
  Int J Med Sci. 5(2)
  
  Pages: 80-86
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590167
[Journal Article] VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.2008
- Author(s)
  Sakaeda T, Yamamori M, Kuwahara A, Hiroe S, Nakamura T, Okumura K, Okuno T, Miki I, Chayahara N, Okamura N, Tamura T
- Journal Title
  
  Ther Drug Monit. 30(4)
  
  Pages: 497-503
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590167
[Journal Article] Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells2007
- Author(s)
  Kawakami M, Nakamura T, Okamura N, Komoto C, Markova S, Kobayashi H, Hashimoto N, Okumura K, Sakaeda T.
- Journal Title
  
  Biol.Pharm.Bull 30
  
  Pages: 1065-1073
- NAID
  110006278393
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590167
[Journal Article] Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells.2007
- Author(s)
  Kawakami M, Nakamura T, Okamura N, Komoto C, Markova S, Kobayashi H, Hashimoto N, Okumura K, Sakaeda T.
- Journal Title
  
  Biol Pharm Bull. 30(6)
  
  Pages: 1065-1073
- NAID
  110006278393
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590167
[Journal Article] Association of cumulative cyclosporine dose with its irreversible nephrotoxicity in Japanese patients with pediatric-onset autoimmune diseases.2007
- Author(s)
  Nakamura T, N ozu K, I ijima K, Y oshikawa N, Moriya Y, Yamamori M, Kako A, Matsuo M, Sakurai A,Okamura N, Ishikawa T, Okumura K, Sakaeda T.
- Journal Title
  
  Biol Pharm Bull. 30(12)
  
  Pages: 2371-2375
- NAID
  110006546441
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590167
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（２）2016
- Author(s)
  山口京子、川上恵、前沙織、本田陽子、山森元博、岡村昇
- Organizer
  日本薬学会第136年会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-03-26
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（２）2016
- Author(s)
  山口京子、川上恵、前沙織、長谷川愛、本田陽子、山森元博、岡村昇
- Organizer
  医療薬学フォーラム2016
- Place of Presentation
  びわ湖ホール（滋賀県大津市）
- Year and Date
  2016-06-25
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（１）2016
- Author(s)
  前沙織、川上恵、山口京子、本田陽子、山森元博、岡村昇
- Organizer
  日本薬学会第136年会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-03-26
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（１）2016
- Author(s)
  前沙織、川上恵、山口京子、長谷川愛、本田陽子、山森元博、岡村昇
- Organizer
  医療薬学フォーラム2016
- Place of Presentation
  びわ湖ホール（滋賀県大津市）
- Year and Date
  2016-06-25
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 15デオキシ-デルタ12 14-プロスタグランジンJ2の細胞膜上における標的分子であるHSP70の抗体は神経細胞死を誘導する2012
- Author(s)
  山本泰弘、高馬宏美、藤田恵、山森元博、中村任、岡村昇、矢上達郎
- Organizer
  Neuroscience 2012
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-24590225
[Presentation] 腎細胞癌に対する15-デオキシ-デルタ12, 14-プロスタグランジンJ2と各種抗腫瘍剤との併用による相乗毒性2012
- Author(s)
  山本泰弘、高馬宏美、藤田恵、山森元博、中村任、岡村昇、矢上達郎
- Organizer
  第85回日本薬理学会年会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] ヒト神経膠芽腫細胞におけるテモゾロミドの効果に及ぼす抗てんかん薬の影響2012
- Author(s)
  西口裕子、藤田恵、稲彩乃、本田陽子、山森元博、岡村昇
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍メカニズムの解明2012
- Author(s)
  田路千明、藤田恵、本田陽子、山本泰弘、中村任、矢上達郎、山森元博、岡村昇
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍効果2011
- Author(s)
  田路千明、藤田恵、澤田京子、山森元博、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞におけるトログリタゾンの抗腫瘍効果に対するp38 MAPK経路の役割2011
- Author(s)
  藤尾弥希、藤田恵、田路千明、澤田京子、山森元博、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 食道がん化学放射線療法における治療成績とフルオロウラシル血漿中濃度との相関2011
- Author(s)
  〓原晶子、山森元博、岡村昇、片岡和三郎、田村孝雄
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 15-デオキシ-デルタ12, 14-プロスタグランジンJ2誘導神経細胞死に対する抗エノラーゼ抗体の効果2011
- Author(s)
  山本泰弘、高瀬堅吉、藤田恵、岡村昇、栄田敏之、矢上達郎
- Organizer
  第34回日本神経科学大会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] ヒト腎臓がん細胞株ACHNに対するZoledronateの抗腫瘍効果2011
- Author(s)
  土肥麻貴子、藤田恵、澤田京子、山森元博、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞におけるトログリタゾンの抗腫瘍活性の検討2010
- Author(s)
  藤田恵、田路千明、澤田京子、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第130年会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 骨髄腫細胞株IM-9に対するzoledronateの抗腫瘍効果2010
- Author(s)
  西部香、藤田恵、澤田京子、岡村昇
- Organizer
  日本薬学会第130年会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 神経細胞膜における15-デオキシ-デルタ12, 14-プロスタグランジンJ2の新規標的タンパク質2010
- Author(s)
  矢上達郎、山本泰弘、高瀬堅吉、岡村昇、栄田敏之
- Organizer
  第33回日本神経科学大会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎細胞癌における診断マーカーおよび創薬ターゲット探索のための定量的プロテオーム解析2008
- Author(s)
  金子直樹, 岡村昇, 増田太郎, 後藤章暢, 白川利朗, 寺尾秀治, 渡辺真, 松原稔哉, 菅沼一樹, 瀬戸亮太, 松本隼, 川上恵, 山森元博, 中村任, 矢上達郎, 栄田敏之, 藤澤正人, 奥村勝彦, 西村紀
- Organizer
  日本ヒトプロテオーム機構第6回大会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-19590167
[Presentation] Quantitative Proteomic Analysis to Discover Potential Diagnostic Markers and Therapeutic Targets in Human Renal Cell Carcinoma2008
- Author(s)
  Naoki Kaneko, Noboru Okamura, Taro Masuda, Akinobu Gotoh, Toshiro Shirakawa, Shuji Terao, Makoto Watanabe, Toshiya Matsubara, Kazuki Suganuma, Ryota Seto, Jun Matsumoto, Megumi Kawakami. Motohiro Yamamori, Tsutomu Nakamura, Tatsurou Yagami, Toshiyuki Sakaeda, Masato Fujisawa, Katsuhiko Okumur, Osamu Nishimura
- Organizer
  第81回日本生化学会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-19590167
[Presentation] Suppression of sorcin mRNA in patients wi th renal cell carcinoma.2008
- Author(s)
  川上恵, 中村任, 岡村昇, 寺尾秀治, 後藤章暢, 白川利朗, 藤津正人, 山森元博, 栄田敏之
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-19590167
[Presentation] Effect of sorcin on VEGF expression in renal cell carcinoma.2007
- Author(s)
  寺尾秀治, 岡村昇, 白川利朗, 中村任, 栄田敏之, 武中篤, 藤津正人, 後藤章暢
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19590167

1. OKUMURA Katsuhiko (60025707)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
2. YAMAMORI Motohiro (10444613)

# of Collaborated Projects: 3 results

# of Collaborated Products: 20 results
3. FUJITA Megumi (50509966)

# of Collaborated Projects: 2 results

# of Collaborated Products: 16 results
4. SAKAEDA Toshiyuki (00304098)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. NAKAMURA Tsutomu (80379411)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
6. GOTOH Akinobu (70283885)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. SHIRAKAWA Toshiro (70335446)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. YAGI Mariko (60362787)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. TAKESHIMA Yasuhiro (40281141)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Okamura Noboru 岡村 昇

OKAMURA Noboru 岡村 昇

Research Projects

Research Products

Co-Researchers

Development for novel therapy for pancreatic cancer by PPARgamma agonistsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Research on the therapy for pancreatic cancer by PPARgamma agonistsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Discovery of novel targets for the treatment of renal cell carcinoma based on tumor proteomicsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Proteomic analysis to discover diagnostic markers in human renal call carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Elucidation of adverse events of methotrexate based on genomic and proteomic analysis in childhood leukemia patients

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Discovery of targets for treatment with renal cell carcinoma by gene and protein expression profile analysis

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential tumor markers of renal cell carcinoma: α-enolase for postoperative follow-up and galectin-1 and galectin-3 for primary detection.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] L-type voltage-dependent calcium channel is involved in the snake venom group IA secretory phospholipase A2-induced neuronal apoptosis.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Involvement of the mevalonate pathway in anti-proliferative effect of zoledronate on renal cell carcinoma2012

Author(s)

Journal Title

Data Source

[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011

Author(s)

Journal Title

Data Source

[Journal Article] 15-Deoxy-Δ12, 14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways2011

Author(s)

Journal Title

Data Source

[Journal Article] Proteomic identification of protein targets for 15-deoxy-Δ12, 14-prostaglandin J2 in neuronal plasma membrane2011

Author(s)

Okamura Noboru 岡村昇

OKAMURA Noboru 岡村昇